Maribavir vs ganciclovir
All‐cause death · solid organ transplant recipients
Maribavir showed no clear difference in all‐cause death compared with ganciclovir (low certainty).
1 finding from 1 review
- Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 2024 · Cochrane Headline outcomes onlyRR 1.5 [0.55, 4.11]1 study · 294 participantsLow